Display Settings:

Format

Send to:

Choose Destination
J Am Acad Dermatol. 2012 Jul;67(1):19.e1-12; quiz 31-2. doi: 10.1016/j.jaad.2012.03.013.

The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.

Author information

  • 1Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA.

Abstract

The dysplastic nevus is a discreet histologic entity that exhibits some clinical and histologic features overlapping with common nevi and melanoma. These overlapping features present a therapeutic challenge, and with a lack of accepted guidelines, the management of dysplastic nevi remains a controversial subject. Although some differences between dysplastic and common nevi can be detected at the molecular level, there are currently no established markers to predict biologic behavior. In part II of this continuing medical education article, we will review the molecular aspects of dysplastic nevi and their therapeutic implications. Our goal is to provide the clinician with an up-to-date understanding of this entity to facilitate clinical management of patients with nevi that have histologic dysplasia.

Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

PMID:
22703916
[PubMed - indexed for MEDLINE]
PMCID:
PMC3621132
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk